European Journal of Surgical Oncology
Volume 36, Issue 8 , Pages 783-788 , August 2010

Ratio of marked and excised sentinel lymph nodes and scintigraphic appearance time in melanoma patients with negative sentinel lymph node

  • E. Richtig

      Affiliations

    • Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, 8036 Graz, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 316 385 2371; fax: +43 316 385 2466.
    • ,
  • P. Komericki

      Affiliations

    • Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, 8036 Graz, Austria
    • ,
  • M. Trapp

      Affiliations

    • University Clinic of Medical Psychology and Psychotherapy, Medical University of Graz, Auenbruggerplatz 43, 8036 Graz, Austria
    • ,
  • A. Ott

      Affiliations

    • Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036 Graz, Austria
    • ,
  • B. Bisail

      Affiliations

    • Department of Nuclear Medicine, Medical University of Graz, Auenbruggerplatz 9, 8036 Graz, Austria
    • ,
  • J.W. Egger

      Affiliations

    • University Clinic of Medical Psychology and Psychotherapy, Medical University of Graz, Auenbruggerplatz 43, 8036 Graz, Austria
    • ,
  • I. Zalaudek

      Affiliations

    • Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, 8036 Graz, Austria

,Accepted 4 May 2010.

References 

  1. Morton DL, Wen DR, Wong JH, et al. Technical details of lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  2. Garbe C, Hauschild A, Volkenandt M, et al. Deutsche Leitlinie: Malignes Melanom. http://www.ado-homepage.de/projekte/1/upload/leitlinie_melanom_ado_2005.pdf2005
  3. Zakrzewski JA, Warycha MA, Ni Q, et al. Meta-analysis of sentinel node positivity in thin melanoma (≤1 mm). J Clin Oncol. May 20 2008;26(Suppl.):abstract 20032
  4. Zapas JL, Coley HC, Beam SL, et al. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel node biopsy. J Am Coll Surg. 2003;197:403–407
  5. Roulin D, Matter M, Bady P, et al. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. Eur J Surg Oncol. 2008;34:673–679
  6. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238:538–549
  7. Rousseau DL, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol. 2003;10:569–574
  8. Berk DR, Johnson DL, Uzieblo A, et al. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997–2004. Arch Dermatol. 2005;141:1016–1022
  9. Zogakis TG, Essner R, Wang H, et al. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes. Ann Surg Oncol. 2007;14:1604–1611
  10. Dalal KM, Patel A, Brady MS, et al. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol. 2007;14:1934–1942
  11. De Giorgi V, Leparatti G, Massi D, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes: a one institutions’s experience. Oncology. 2007;73:401–406
  12. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253–2260
  13. Yee VS, Thompson JF, McKinnon JG, et al. Outcome of 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol. 2005;12:429–439
  14. Fincher TR, McCarty TM, Fisher TL, et al. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg. 2003;186:675–681
  15. Nieweg OE, Estourgie SH. What is a sentinel node and what is a false-negative sentinel node?. Ann Surg Oncol. 2004;11:169S–173S
  16. Alazraki N, Glass EC, Castronovo F, et al. Procedure guideline for lymphoscintigraphy and use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0. J Nucl Med. 2002;43:1414–1418
  17. Cochran AJ, Huang RR, Guo J, Wen DR. Current practice and future directions in pathology and laboratory evaluation of the sentinel node. Ann Surg Oncol. 2001;8(Suppl. 9):13–17
  18. Balch CM, Buzaid AC, Seng-Jaw S, et al. Final version of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–3648
  19. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317
  20. Roka F, Mastan P, Binder M, et al. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. Eur J Surg Oncol. 2008;34:82–88
  21. Rossi CR, De Salvo GL, Trifiro G, et al. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian multicentric study (SOLISM-IMI). J Nucl Med. 2006;47:234–241
  22. Van Akkooi AC, de Wilt JH, Verhoef C, et al. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic pattern after sentinel node biopsy in melanoma. Eur J Cancer. 2006;42:372–380
  23. Li LL, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197–1202
  24. Schmidt CR, Panageas KS, Coit DG, et al. An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma. Ann Surg Oncol. 2009;16(4):948–952
  25. Conway WC, Faries MB, Terando AM, Glass EC, Sim M, Morton DL. Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol. 2009;16(6):1548–1552
  26. Mahieu-Renard L, Cammilleri S, Giorgi R, et al. Slow dynamics of lymphoscintigraphic mapping is associated to the negativity of the sentinel node in melanoma patients. Ann Surg Oncol. 2008;15:2878–2886
  27. Clary BM, Brady MS, Lewis JJ, Coit DG. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with emphasis on recurrence. Ann Surg. 2001;233:250–258

PII: S0748-7983(10)00111-3

doi: 10.1016/j.ejso.2010.05.003

European Journal of Surgical Oncology
Volume 36, Issue 8 , Pages 783-788 , August 2010

Article Tools